Where Do We Go from Here? Optimizing America’s Health Care Strategy for Advancing Responsible AI

1:00 PM - 2:00 PM (PDT), Monday, June 13, 2022 ・ Upper Level, Session Room 5B

Learn how different organizations are approaching using AI/ML, their thoughts on the challenges and opportunities with regulatory acceptance of approaches in drug development, how these efforts can improve clinical trial diversity, and what we need to move forward.

Moderator
photo
Senior Director, Science & Regulatory Affairs
Biotechnology Innovation Organization
Speakers
photo
Vice President, Regulatory
Recursion Pharmaceuticals, Inc.
photo
Senior Director of Public Policy
Amicus Therapeutics, Inc.
photo
President and CEO
Cyclica, Inc
photo
CEO
EVQLV, Inc